| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 05/06/2009 | CN101426807A Neuroprotective compounds and uses thereof |
| 05/06/2009 | CN101423546A Radioactive rhenium marked polypeptide containing RGD sequence as well as preparation method and application thereof |
| 05/05/2009 | US7528249 Amidating a cyclic carboxylic acid (methyl 1-[N-(3-methylbutyl)carbamoyl]cyclopentane-carboxylic acid) with an aminobenzodiazepinone (3-amino-1-methyl-5-phenyl-3H-benzoazepin-2-one) |
| 05/05/2009 | US7528228 For use as medicinal products, as intermediates for producing peptides and as a spacer arm in pharmaceutical compositions intended to take biologically active principles specifically to certain cells of the body |
| 05/05/2009 | US7528223 Polypeptide encoded by an alternative reading frame of an influenza virus |
| 05/05/2009 | US7528152 synthetic analog of Hemiasterlin; anticarcinogenic agent; restenosis of blood vessels subject to traumas such as angioplasty and stenting; safe and effective, while retaining stability in biological media; exhibit low cytotoxicity to non-dividing normal cells |
| 05/05/2009 | CA2386230C Modulators of cytokine mediated signalling pathways and integrin .alpha.v.beta.3 receptor antagonists for combination therapy |
| 04/30/2009 | WO2008157483A3 Polypeptides and methods of use |
| 04/30/2009 | WO2008132759A3 Industrially advantageous process for the production of lisinopril dihydrate |
| 04/30/2009 | WO2006060643A3 Novel bladder matrix protein peptides and methods of detection of bladder cancer |
| 04/30/2009 | US20090111969 Macrocyclic compounds as inhibitors of viral replication |
| 04/30/2009 | US20090111757 Hcv protease inhibitors |
| 04/30/2009 | US20090111731 Novel topical application agents against mimic and age-related wrinkles |
| 04/30/2009 | US20090111195 Chemical reagents and methods for detection and quantification of proteins in complex mixtures |
| 04/30/2009 | US20090110682 Antibody Having Inhibitory Effect on Amyloid Fibril Formation |
| 04/30/2009 | CA2703491A1 Tubulysins and processes for preparing |
| 04/30/2009 | CA2703133A1 Antibody-mediated disruption of quorum sensing in bacteria |
| 04/29/2009 | EP2052011A1 Targeted polylysine dendrimer therapeutic agent |
| 04/29/2009 | EP2051991A1 Cardioprotective compounds |
| 04/29/2009 | EP2051990A1 Smac peptidomimetics useful as iap inhibitors |
| 04/29/2009 | EP1485347B1 Hif hydroxylase inhibitors for use in the treatment of anaemia |
| 04/29/2009 | EP1343807B1 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus |
| 04/29/2009 | EP1105413B1 Hepatitis c inhibitor tri-peptides |
| 04/29/2009 | CN101421417A PCR hot start by magnesium sequestration |
| 04/29/2009 | CN101421293A Peptide lipid-containing carrier and method for introducing compound into cells using same |
| 04/29/2009 | CN101421292A HCV inhibitors |
| 04/29/2009 | CN101421291A Process for the manufacture of lysobactin derivatives |
| 04/29/2009 | CN101418035A Novel dipeptide (Boc-Gly-Pro-OH) synthetic process |
| 04/29/2009 | CN100482681C Synthesis of n- [n-(3,3-dimethylbutyl)-l-a-aspartyl] -l-phenylalanine 1-methyl ester using 3,3-dimethylbutyraldehyde precursors |
| 04/29/2009 | CN100482680C Prodrugs of excitatory amino acids |
| 04/28/2009 | US7524883 Eponemycin and epoxomicin analogs and uses thereof |
| 04/28/2009 | US7524820 Administering one or more enzyme inhibitors, selected from tripeptides, tetrapeptides and pentapeptides, to inhibit neucrosis factor kappa Beta mediated inflammatory cytokine release |
| 04/28/2009 | US7524819 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 04/28/2009 | CA2197653C Delivery of nucleic acids |
| 04/23/2009 | WO2009051581A1 Proteasome inhibitors |
| 04/23/2009 | WO2009015382A3 Novel peptides that enhance tight junction permeability |
| 04/23/2009 | WO2009012958A3 Tubulysin d analogues |
| 04/23/2009 | WO2007135684A3 Method of treatment of anti-cd4 autoimmunity |
| 04/23/2009 | WO2006071843A3 Biomarkers for breast cancer |
| 04/23/2009 | WO2006061851A3 Method for production of a therapeutically pure granulocyte macrophage - colony stimulating factor |
| 04/23/2009 | US20090105159 Neuroprotective Compounds and Uses Thereof |
| 04/23/2009 | US20090105156 Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides |
| 04/23/2009 | US20090105091 Modified Amino Acids |
| 04/22/2009 | EP2049563A2 Dimeric iap antagonists |
| 04/22/2009 | EP1551865B1 Hybrid molecules of macrolides with steroidal/non-steroidal anti-inflammatory molecules |
| 04/22/2009 | EP1392719B1 Forms of prostate specific antigens and methods for their detection |
| 04/22/2009 | CN101415724A Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases |
| 04/22/2009 | CN101415723A HIV fusion inhibitor peptides with improved biological properties |
| 04/21/2009 | US7521530 Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2α receptor |
| 04/21/2009 | US7521529 Lantibiotics; biosynthesis; solid phase synthesis; deblocking, deprotecting |
| 04/21/2009 | US7521477 Vitamin C derivatives with peptide, preparation method thereof and composition comprising the same |
| 04/21/2009 | US7521466 Dipeptide phenyl ethers |
| 04/21/2009 | US7521427 provides compositions for inhibiting proteases, methods for synthesizing the compositions, and methods of using the disclosed protease inhibitors. Aspects of the disclosure include peptidyl allyl sulfone compositions that inhibit proteases, for example cysteine proteases, either in vivo or in vitro. |
| 04/21/2009 | US7521423 Exendin pharmaceutical compositions |
| 04/21/2009 | US7521420 Macrocyclic antagonists of the motilin receptor |
| 04/21/2009 | US7521419 Peptide-based compounds |
| 04/21/2009 | US7521416 D-amino acid peptides |
| 04/21/2009 | US7521055 Detecting variant allele of human ferroportin1 gene and evaluating DNA sequence; administering inhibitor of Ferroportin1 iron transport function; oxidative damage in mammals, iron deficiency, hemochromatosis, anemia, and blood disorders; replication; administering polypeptide, immune response |
| 04/16/2009 | WO2009047728A2 New s-acyl-glutathione derivatives, their syntesis and use in the treatment of oxidative stress-related diseases |
| 04/16/2009 | WO2008070672A3 Compositions and methods to treat cancer with cupredoxins and cpg rich dna |
| 04/16/2009 | WO2008049583A3 Process for selectively localizing active ingredients on and in mitochondria and corresponding active ingredients |
| 04/16/2009 | WO2007030451A3 Antibodies as t cell receptor mimics, methods of production and uses thereof |
| 04/16/2009 | WO2006138449A3 Method for identifying a mhc class ii-dependent tumor-associated t helper cell antigen |
| 04/16/2009 | WO2006093814A3 Fgf growth factor analogs |
| 04/16/2009 | US20090099098 peptide lysyl-glutamyl-asparagine acid capable of enhancing capillaries resistance; for treatment of purpura senilis; normalization of blood microcirculation |
| 04/16/2009 | US20090099097 Enzyme inhibition |
| 04/16/2009 | US20090099096 HIV proteases as therapeutic agents for inhibition and treatment of HIV infection in humans, administered in combination with other classes of HIV therapeutic agents, especially inhibitors of HIV reverse transcriptase |
| 04/16/2009 | US20090098577 Method of identifying compounds that modulate caspase 9 activity via use of a kosmotropic salt |
| 04/15/2009 | EP2046813A2 Protein-binding methotrexate derivatives, and medicaments containing the same |
| 04/15/2009 | EP2046778A1 Multifunctional bioactive compounds |
| 04/15/2009 | CN101407539A Oligopeptide having marrow hemopoiesis protection function, preparation thereof, pharmaceutical composition containing the oligopeptide and use |
| 04/14/2009 | US7517971 Muteins of human telomerase reverse transcriptase lacking telomerase catalytic activity |
| 04/14/2009 | US7517948 Hsp70 peptide stimulating natural killer (NK) cell activity and uses thereof |
| 04/14/2009 | US7517857 Binding to formyl peptide receptor or formyl peptide receptor-like 1; induce superoxide generation by human monocytes or neutrophils; induce chemotactic migration of human monocytes or neutrophils in vitro; that induce degranulation in formyl peptide receptor expressing cells or formyl peptide receptor-l |
| 04/14/2009 | US7517855 Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof |
| 04/14/2009 | US7517849 ATP-binding cassette transporter protein-inhibiting peptide; impair the functioning of the ABC transporter responsible for conferring resistance to chemotherapeutic agents cancer cells, rendering them more susceptible to killing by standard chemotherapeutic agents; 1st peptide end negatively charged |
| 04/09/2009 | WO2009046098A1 Novel cyclic boronate inhibitors of hcv replication |
| 04/09/2009 | WO2009045497A1 Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides |
| 04/09/2009 | WO2009043114A1 Arsenoxide compound and method of use |
| 04/09/2009 | WO2008144659A3 Dickkopf-1 (dkk1) as a universal tumor vaccine for immunotherapy of cancers |
| 04/09/2009 | WO2008070666A3 Compositions and methods to treat cancer with cpg rich dna and cupredoxins |
| 04/09/2009 | WO2005111073A3 Channel forming peptides |
| 04/09/2009 | US20090093639 Prodrugs of carbamate inhibitors of IMPDH |
| 04/09/2009 | US20090093541 Melanin eliminator preparation |
| 04/09/2009 | US20090093534 Mu opioid receptor ligands: methods of use and synthesis |
| 04/09/2009 | US20090093416 Caspase inhibitors and uses thereof |
| 04/09/2009 | US20090093414 methotrexate- alpha -PhePhe-NHC10H20O3NHCO O-hyaluronic acid; therapeutical agent; oseoarthritis (degenerative diseases ) |
| 04/09/2009 | US20090093057 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 04/09/2009 | DE10208877B4 Verwendung eines Streptavidin- Bindungspeptides Using a streptavidin-binding peptide |
| 04/09/2009 | CA2701778A1 Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides |
| 04/08/2009 | EP2044101A2 Aminothiazole derivatives and their uses as antibacterial agents |
| 04/08/2009 | EP2044010A1 New pharmaceutical intermediates in the synthesis of ace- inhibitors and the use thereof |
| 04/08/2009 | EP2043671A2 Method and compositions for treating stroke with fever |
| 04/08/2009 | EP1718667A4 Heterocyclic self-immolative linkers and conjugates |
| 04/08/2009 | EP1513811B1 Non-peptidic brs-3 agonists |
| 04/08/2009 | CN101405294A Compounds for enzyme inhibition |
| 04/08/2009 | CN100475837C Branched polyglycol-amino acid oligopeptide and active derivative and medicinal composition thereof |
| 04/08/2009 | CN100475836C Mesenchymal stem cell affinity peptide screening and use |
| 04/07/2009 | US7514557 Hepatitis C; preparing 8-bromo-7-alkoxyquinolines 2-substituted with a hetercyclic ring having an amine, carbamate, amine or urea group an 4-substituted with a 3-prolineoxy- group or derivative; intermediates |
| 04/07/2009 | US7514538 Compositions and methods for the diagnosis and treatment of tumor |